JPH04139132A - Anti-active oxygen action composition, anti-active oxygen agent, food, cosmetic and medicine containing the same as active ingredient - Google Patents
Anti-active oxygen action composition, anti-active oxygen agent, food, cosmetic and medicine containing the same as active ingredientInfo
- Publication number
- JPH04139132A JPH04139132A JP2257485A JP25748590A JPH04139132A JP H04139132 A JPH04139132 A JP H04139132A JP 2257485 A JP2257485 A JP 2257485A JP 25748590 A JP25748590 A JP 25748590A JP H04139132 A JPH04139132 A JP H04139132A
- Authority
- JP
- Japan
- Prior art keywords
- composition
- active oxygen
- added
- plant seeds
- active
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 86
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 title claims abstract description 62
- 239000001301 oxygen Substances 0.000 title claims abstract description 62
- 229910052760 oxygen Inorganic materials 0.000 title claims abstract description 62
- 239000002537 cosmetic Substances 0.000 title claims abstract description 13
- 235000013305 food Nutrition 0.000 title claims abstract description 9
- 239000003795 chemical substances by application Substances 0.000 title claims description 7
- 239000003814 drug Substances 0.000 title abstract description 13
- 239000004480 active ingredient Substances 0.000 title description 4
- 239000012454 non-polar solvent Substances 0.000 claims abstract description 9
- 239000002798 polar solvent Substances 0.000 claims abstract description 9
- 238000000605 extraction Methods 0.000 claims description 7
- 210000002257 embryonic structure Anatomy 0.000 claims description 3
- 102000004190 Enzymes Human genes 0.000 claims 1
- 108090000790 Enzymes Proteins 0.000 claims 1
- 239000000825 pharmaceutical preparation Substances 0.000 claims 1
- 229940127557 pharmaceutical product Drugs 0.000 claims 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract description 27
- 239000000126 substance Substances 0.000 abstract description 24
- 230000000694 effects Effects 0.000 abstract description 17
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 abstract description 15
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 abstract description 14
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 abstract description 14
- 239000002994 raw material Substances 0.000 abstract description 9
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 abstract description 6
- 238000007796 conventional method Methods 0.000 abstract description 6
- 230000002829 reductive effect Effects 0.000 abstract description 6
- 238000005406 washing Methods 0.000 abstract description 4
- 244000005700 microbiome Species 0.000 abstract description 3
- 239000000284 extract Substances 0.000 abstract description 2
- 238000000855 fermentation Methods 0.000 abstract description 2
- 230000004151 fermentation Effects 0.000 abstract description 2
- 239000004615 ingredient Substances 0.000 abstract description 2
- 238000004040 coloring Methods 0.000 abstract 1
- 210000001161 mammalian embryo Anatomy 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 22
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 21
- 201000010099 disease Diseases 0.000 description 16
- 239000007787 solid Substances 0.000 description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 16
- 241000196324 Embryophyta Species 0.000 description 10
- 240000007594 Oryza sativa Species 0.000 description 10
- 235000007164 Oryza sativa Nutrition 0.000 description 10
- 235000009566 rice Nutrition 0.000 description 10
- 238000002360 preparation method Methods 0.000 description 9
- 235000019439 ethyl acetate Nutrition 0.000 description 8
- 239000000843 powder Substances 0.000 description 8
- 238000003756 stirring Methods 0.000 description 8
- 241000209140 Triticum Species 0.000 description 6
- 235000021307 Triticum Nutrition 0.000 description 6
- 208000035475 disorder Diseases 0.000 description 6
- 244000068988 Glycine max Species 0.000 description 5
- 235000010469 Glycine max Nutrition 0.000 description 5
- 240000005979 Hordeum vulgare Species 0.000 description 5
- 235000007340 Hordeum vulgare Nutrition 0.000 description 5
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 5
- 229930006000 Sucrose Natural products 0.000 description 5
- 239000002775 capsule Substances 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 239000000796 flavoring agent Substances 0.000 description 5
- 230000036541 health Effects 0.000 description 5
- -1 lipid peroxides Chemical class 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 239000005720 sucrose Substances 0.000 description 5
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 4
- 244000052616 bacterial pathogen Species 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 235000013355 food flavoring agent Nutrition 0.000 description 4
- 239000008187 granular material Substances 0.000 description 4
- 239000007924 injection Substances 0.000 description 4
- 238000002347 injection Methods 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- 239000002674 ointment Substances 0.000 description 4
- 239000003755 preservative agent Substances 0.000 description 4
- 239000006188 syrup Substances 0.000 description 4
- 235000020357 syrup Nutrition 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 208000002874 Acne Vulgaris Diseases 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 230000002292 Radical scavenging effect Effects 0.000 description 3
- 244000000231 Sesamum indicum Species 0.000 description 3
- 235000003434 Sesamum indicum Nutrition 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 206010000496 acne Diseases 0.000 description 3
- 235000021329 brown rice Nutrition 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 238000012423 maintenance Methods 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 206010048628 rheumatoid vasculitis Diseases 0.000 description 3
- 235000002639 sodium chloride Nutrition 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 239000003981 vehicle Substances 0.000 description 3
- GVJHHUAWPYXKBD-IEOSBIPESA-N (R)-alpha-Tocopherol Natural products OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 206010003210 Arteriosclerosis Diseases 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 241000167854 Bourreria succulenta Species 0.000 description 2
- 206010009900 Colitis ulcerative Diseases 0.000 description 2
- 244000018436 Coriandrum sativum Species 0.000 description 2
- 229920002261 Corn starch Polymers 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- 206010014970 Ephelides Diseases 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 208000003351 Melanosis Diseases 0.000 description 2
- NTIZESTWPVYFNL-UHFFFAOYSA-N Methyl isobutyl ketone Chemical compound CC(C)CC(C)=O NTIZESTWPVYFNL-UHFFFAOYSA-N 0.000 description 2
- UIHCLUNTQKBZGK-UHFFFAOYSA-N Methyl isobutyl ketone Natural products CCC(C)C(C)=O UIHCLUNTQKBZGK-UHFFFAOYSA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 208000006011 Stroke Diseases 0.000 description 2
- 201000006704 Ulcerative Colitis Diseases 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 229940087168 alpha tocopherol Drugs 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 208000011775 arteriosclerosis disease Diseases 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 235000019693 cherries Nutrition 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 235000005822 corn Nutrition 0.000 description 2
- 239000008120 corn starch Substances 0.000 description 2
- 229940099112 cornstarch Drugs 0.000 description 2
- 235000012343 cottonseed oil Nutrition 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 2
- 239000002024 ethyl acetate extract Substances 0.000 description 2
- 235000003599 food sweetener Nutrition 0.000 description 2
- 235000013376 functional food Nutrition 0.000 description 2
- 235000013402 health food Nutrition 0.000 description 2
- 208000006454 hepatitis Diseases 0.000 description 2
- 231100000283 hepatitis Toxicity 0.000 description 2
- 235000015110 jellies Nutrition 0.000 description 2
- 239000008274 jelly Substances 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 208000010125 myocardial infarction Diseases 0.000 description 2
- 201000008383 nephritis Diseases 0.000 description 2
- 239000000575 pesticide Substances 0.000 description 2
- 235000019271 petrolatum Nutrition 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 2
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 235000021067 refined food Nutrition 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 235000019685 rice crackers Nutrition 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000011343 solid material Substances 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 239000003765 sweetening agent Substances 0.000 description 2
- 229960000984 tocofersolan Drugs 0.000 description 2
- AOBORMOPSGHCAX-DGHZZKTQSA-N tocofersolan Chemical compound OCCOC(=O)CCC(=O)OC1=C(C)C(C)=C2O[C@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C AOBORMOPSGHCAX-DGHZZKTQSA-N 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- 239000008158 vegetable oil Substances 0.000 description 2
- 239000002076 α-tocopherol Substances 0.000 description 2
- 235000004835 α-tocopherol Nutrition 0.000 description 2
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 240000006439 Aspergillus oryzae Species 0.000 description 1
- 235000002247 Aspergillus oryzae Nutrition 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- 240000002791 Brassica napus Species 0.000 description 1
- 235000004977 Brassica sinapistrum Nutrition 0.000 description 1
- 244000020518 Carthamus tinctorius Species 0.000 description 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 description 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 229920002884 Laureth 4 Polymers 0.000 description 1
- 244000246386 Mentha pulegium Species 0.000 description 1
- 235000016257 Mentha pulegium Nutrition 0.000 description 1
- 235000004357 Mentha x piperita Nutrition 0.000 description 1
- 229920000881 Modified starch Polymers 0.000 description 1
- 241000219925 Oenothera Species 0.000 description 1
- 235000004496 Oenothera biennis Nutrition 0.000 description 1
- 240000007817 Olea europaea Species 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 235000004347 Perilla Nutrition 0.000 description 1
- 244000124853 Perilla frutescens Species 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 235000006089 Phaseolus angularis Nutrition 0.000 description 1
- 240000004713 Pisum sativum Species 0.000 description 1
- 235000010582 Pisum sativum Nutrition 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 244000088415 Raphanus sativus Species 0.000 description 1
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 229920001800 Shellac Polymers 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 238000000944 Soxhlet extraction Methods 0.000 description 1
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 1
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- 240000007098 Vigna angularis Species 0.000 description 1
- 235000010711 Vigna angularis Nutrition 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 239000012752 auxiliary agent Substances 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 235000007215 black sesame Nutrition 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000006172 buffering agent Substances 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000005779 cell damage Effects 0.000 description 1
- 208000037887 cell injury Diseases 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 239000007958 cherry flavor Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 238000010908 decantation Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 230000006806 disease prevention Effects 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 description 1
- 229940093471 ethyl oleate Drugs 0.000 description 1
- 239000010685 fatty oil Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000010855 food raising agent Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 1
- 235000001050 hortel pimenta Nutrition 0.000 description 1
- TUJKJAMUKRIRHC-UHFFFAOYSA-N hydroxyl Chemical compound [OH] TUJKJAMUKRIRHC-UHFFFAOYSA-N 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 229960003511 macrogol Drugs 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- 239000007968 orange flavor Substances 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 239000004208 shellac Substances 0.000 description 1
- ZLGIYFNHBLSMPS-ATJNOEHPSA-N shellac Chemical compound OCCCCCC(O)C(O)CCCCCCCC(O)=O.C1C23[C@H](C(O)=O)CCC2[C@](C)(CO)[C@@H]1C(C(O)=O)=C[C@@H]3O ZLGIYFNHBLSMPS-ATJNOEHPSA-N 0.000 description 1
- 229940113147 shellac Drugs 0.000 description 1
- 235000013874 shellac Nutrition 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 229940031439 squalene Drugs 0.000 description 1
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 1
- 239000008174 sterile solution Substances 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 239000000196 tragacanth Substances 0.000 description 1
- 235000010487 tragacanth Nutrition 0.000 description 1
- 229940116362 tragacanth Drugs 0.000 description 1
- VLPFTAMPNXLGLX-UHFFFAOYSA-N trioctanoin Chemical compound CCCCCCCC(=O)OCC(OC(=O)CCCCCCC)COC(=O)CCCCCCC VLPFTAMPNXLGLX-UHFFFAOYSA-N 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000008215 water for injection Substances 0.000 description 1
- 239000003021 water soluble solvent Substances 0.000 description 1
- 239000003871 white petrolatum Substances 0.000 description 1
Landscapes
- Grain Derivatives (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
【発明の詳細な説明】
〔産業上の利用分野〕
本発明は成人病、悪性関節リウマチ、バーチエツト病等
の難病などの健康維持上障害となる諸疾患、火傷などの
外傷、ニキビ、シミ等の美容上の障害の予防、治療に効
果を有する新規抗活性酸素作用を有する組成物並びに、
この組成物を有効成分として含有する抗活性酸素剤、加
工食品、健康食品、機能性食品、化粧料及び医薬品に関
するものである。[Detailed Description of the Invention] [Field of Industrial Application] The present invention is useful for treating various diseases that impede health maintenance such as adult diseases, malignant rheumatoid arthritis, and intractable diseases such as Bartchet's disease, injuries such as burns, acne, and age spots. A composition having a novel anti-reactive oxygen effect that is effective in the prevention and treatment of cosmetic disorders, and
The present invention relates to anti-active oxygen agents, processed foods, health foods, functional foods, cosmetics, and pharmaceuticals containing this composition as an active ingredient.
近年、動脈硬化症、脳卒中症、高血圧症、心筋梗塞症、
癌、糖尿病等の成人病を始め、悪性関節リウマチ、バー
チエツト病、クーロン氏病、潰瘍性大腸炎、肝炎、腎炎
等の難病、化学物質(例えば農薬等)で惹起される疾患
等が健康維持上障害となっている。また、火傷などの外
傷、ニキビ、シラシン、皮膚炎、シミ、ソバカス等が美
容上の障害となっている。In recent years, arteriosclerosis, stroke, hypertension, myocardial infarction,
Adult diseases such as cancer and diabetes, incurable diseases such as malignant rheumatoid arthritis, Bartchett's disease, Coulomb's disease, ulcerative colitis, hepatitis, and nephritis, as well as diseases caused by chemicals (e.g., pesticides, etc.) are important for maintaining health. It has become an obstacle. In addition, external injuries such as burns, acne, cilantro, dermatitis, age spots, freckles, and the like pose cosmetic problems.
これらの各種障害は、必ずしも同一の原因により発症す
るものではないが、人体に対し直接障害を与えるものと
して、外的刺激で人体内に過剰の活性酸素や過酸化脂質
(以下、活性酸素等と言う)が生成し、細胞障害に関与
していることが知られている。These various disorders do not necessarily develop from the same cause, but they are caused by excessive active oxygen and lipid peroxides (hereinafter referred to as active oxygen, etc.) in the human body due to external stimulation. ) is produced and is known to be involved in cell damage.
従来、これらの活性酸素等を抑制する物質として、植物
種子又は胚芽を焙煎し、次いで微生物を加えて醗酵せし
め、これに植物油や植物種子を添加してなる組成物が特
開昭63−79834号公報等に開示されている。Conventionally, as a substance for suppressing these active oxygens, a composition is prepared by roasting plant seeds or germs, then adding microorganisms and fermenting them, and adding vegetable oil and plant seeds to this, as disclosed in JP-A-63-79834. It is disclosed in the publication number etc.
上記植物種子又は胚芽を原料とし、焙煎、醗酵させた活
性酸素抑制組成物は、成程度の有効性はあるが、1日の
経口服用量が9〜15gと極めて大量であるため、非経
口はもちろん、経口圧用の形態としても実際には適用し
難い点がある。また、経口以外の投与形態、例えば外用
剤、化粧料、注射剤等にする場合も有効成分の組成物中
杭活性酸素成分以外の成分が多く、製剤化し利用するこ
とに難点があった。更に、摂取を容易にするに小型加工
食品、例えばせんべい、クツキー、あめ等の素材とする
のも適当ではなかった。The active oxygen suppressing composition made from the above-mentioned plant seeds or germs and roasted and fermented has some degree of effectiveness, but since the daily oral dose is extremely large at 9 to 15 g, it cannot be administered parenterally. Of course, it is difficult to actually apply it as a form for oral pressure. In addition, even in the case of administration forms other than oral preparations, such as external preparations, cosmetics, injections, etc., the active ingredient composition contains many components other than the active oxygen component, making it difficult to formulate and utilize them. Furthermore, in order to make it easier to ingest, it was not appropriate to use it as an ingredient in small processed foods such as rice crackers, kutuki, and candy.
本発明は上記活性酸素抑制組成物からその抗滑性酸素成
分類をより高純度に抽出した抗滑性酸素作用組成物並び
にその組成物を含有する食品、化粧料、医薬品及び医薬
部外品等を提供することを目的とするものである。The present invention relates to an anti-slip oxygen effect composition obtained by extracting the anti-slip oxygen component from the above-mentioned active oxygen suppressing composition with higher purity, and foods, cosmetics, pharmaceuticals, quasi-drugs, etc. containing the composition. The purpose is to provide the following.
〔課題を解決するための手段1
本発明者らは、上記課題を解決するため鋭意研究の結果
、植物種子及び/又は胚芽を焙煎し、醗酵させた活性酸
素抑制組成物(原料物質)中の抗活性酸素物質は極性溶
媒によく溶解し、非極性溶媒に不溶であることを見出し
、更に、非極性溶媒で原料中の活性酸素抑制作用の不活
性な物質である色素、脂溶性物質が除去されることも見
出した。これらの溶媒を組み合せることで、原料物質の
総活性以上の活性を保有し、重量として1710以下に
濃縮された抗活性酸素作用を有する組成物を得ることが
でき、本発明を完成した。[Means for Solving the Problems 1] As a result of intensive research to solve the above problems, the present inventors found that an active oxygen suppressing composition (raw material) prepared by roasting and fermenting plant seeds and/or embryos. It was discovered that anti-reactive oxygen substances dissolve well in polar solvents and are insoluble in non-polar solvents.Furthermore, it was found that pigments and fat-soluble substances, which are inert substances that inhibit active oxygen in raw materials, are dissolved in non-polar solvents. It was also found that it was removed. By combining these solvents, it was possible to obtain a composition having an anti-active oxygen effect that has an activity greater than the total activity of the raw materials and is concentrated to a weight of 1710 or less, thereby completing the present invention.
本発明は植物種子及び/又は胚芽類を焙煎した後、酵素
処理したものに植物種子を加えて得られる組成物を非極
性溶媒で洗浄し、その後不溶物を極性溶媒で抽出してな
る抗活性酸素作用の大なる組成物並びに同組成物を含有
する抗活性酸素剤、食品、化粧料、医薬品及び医薬部外
品等である。In the present invention, after roasting plant seeds and/or embryos, the plant seeds are added to the enzymatically treated composition, the resulting composition is washed with a non-polar solvent, and then the insoluble matter is extracted with a polar solvent. These include compositions with a large active oxygen effect, and anti-active oxygen agents, foods, cosmetics, pharmaceuticals, and quasi-drugs containing the same compositions.
本発明に使用する植物種子、胚芽類を焙煎した後、醗酵
させた活性酸素抑制組成物は、例えば米、小麦、大麦、
大豆、とうもろこし、はとむぎ、小豆、えんどう等の植
物種子及び/又は例えば米ぬか、小麦胚芽等の上記植物
種子の胚芽類を麹かび、イースト等の醗酵処理によって
低分子の抗活性酸素物質を大量に遊離生成し、抗活性酸
素活性を強化したものである。この組成物に抹茶、ごま
を加え、更にごま、大豆、綿実、とうもろこし、サフラ
ワー、月見草、ぬか、菜種、オリーブ等の植物種子を加
える。The active oxygen suppressing composition used in the present invention is prepared by roasting and fermenting plant seeds and germs, such as rice, wheat, barley,
Plant seeds such as soybeans, corn, pearl barley, adzuki beans, and peas and/or germs of the above plant seeds such as rice bran and wheat germ are fermented with koji mold, yeast, etc. to produce large amounts of low-molecular anti-active oxygen substances. It is produced freely and has enhanced anti-reactive oxygen activity. Matcha and sesame are added to this composition, as well as plant seeds such as sesame, soybean, cottonseed, corn, safflower, evening primrose, rice bran, rapeseed, and olive.
本発明の上記組成物は、例えば次の方法で得ることがで
きる。The above composition of the present invention can be obtained, for example, by the following method.
全重量に対して、合計60〜80重量%のはとむぎ、大
豆、小麦胚芽及び米ぬか及び/又は玄米胚芽からなる主
成分を、50〜150°Cで蒸すか、又は50〜150
℃で焙煎、又は遠赤外線で焙煎し、その後に蒸し、しか
る後に微生物を加えてよくかきまぜながら発酵し、発酵
終了後に30〜20重量%のごまの微粉末及び10〜O
重量%の緑葉抹(抹茶)を加えて、活性酸素抑制組成物
を製造する。The main ingredients consisting of pearl barley, soybean, wheat germ and rice bran and/or brown rice germ in a total amount of 60 to 80% by weight based on the total weight are steamed at 50 to 150 ° C or 50 to 150 ° C.
Roast at ℃ or roast with far infrared rays, then steam, then add microorganisms and ferment while stirring well. After fermentation, 30~20% by weight of fine sesame powder and 10~O
% by weight of green leaf matcha (matcha) is added to produce an active oxygen suppressing composition.
前記はとむぎ、大豆、小麦胚芽及び米ぬか及び/又は玄
米胚芽の各々を7.5〜27.5重量%にすることが好
ましい。It is preferable that each of the pearl barley, soybean, wheat germ, rice bran and/or brown rice germ be 7.5 to 27.5% by weight.
上記活性酸素抑制組成物中に含まれる抗活性酸素物質の
化学構造は不明であるが、比較的分子量の小なる物質で
あると考えられる。そこで、溶媒での抽出が可能である
と考え、各種溶媒で抽出し、その抗活性酸素活性を測定
したところ、エタノール〉アセトン〉メチルイソブチル
ケトン〉酢酸エチル〉エーテル〉n−ヘキサン〉ベンゼ
ンどなる。このように抗活性酸素物質は極性溶媒に比較
的良く溶ける物質である。Although the chemical structure of the anti-active oxygen substance contained in the active oxygen suppressing composition is unknown, it is thought to be a substance with a relatively small molecular weight. Therefore, we thought that extraction with a solvent was possible, and when we extracted with various solvents and measured their anti-active oxygen activity, we found that ethanol>acetone>methyl isobutyl ketone>ethyl acetate>ether>n-hexane>benzene. As described above, anti-active oxygen substances are substances that are relatively well soluble in polar solvents.
従って、本発明において非極性溶媒で洗浄することによ
って、抗活性酸素物質を失うことなく、原料組成物中の
抗活性酸素作用のない色素、脂溶性物質等が除去される
。次に、このようにして得られた原料組成物の非極性溶
媒に不溶成分を極性溶媒で抽出すると、抗活性酸素物質
が抽出され、原料組成物の1/lO以下の重量になる。Therefore, in the present invention, by washing with a non-polar solvent, pigments, fat-soluble substances, etc. that do not have anti-active oxygen effects in the raw material composition are removed without losing the anti-active oxygen substances. Next, when the non-polar solvent-insoluble components of the raw material composition thus obtained are extracted with a polar solvent, the anti-active oxygen substance is extracted and the weight becomes less than 1/1O of the raw material composition.
上記洗浄工程において、使用する非極性溶媒としてはベ
ンゼン、n−ヘキサン、エーテル等が好適であり、この
洗浄操作は常温下で繰り返し行うか、ソックスレー式抽
出法で行うことも出来る。In the above-mentioned washing step, benzene, n-hexane, ether, etc. are suitable as non-polar solvents to be used, and this washing operation can be carried out repeatedly at room temperature or by Soxhlet extraction method.
上記抽出工程において使用する極性溶媒としては水、水
に溶解する溶媒例えば低級アルコール、アセトン、アル
キルケトン、酢酸エステル等特にアセトン、低級アルコ
ール類が好適である。これらの極性溶媒を2種以上に混
ぜ合わせて使用してもよい。抽出操作は常温でも行うこ
とが出来るが、60〜120℃程度の加温下で行うのが
好適である。As the polar solvent used in the above extraction step, water, water-soluble solvents such as lower alcohols, acetone, alkyl ketones, acetic esters, and especially acetone and lower alcohols are preferable. Two or more of these polar solvents may be used in combination. Although the extraction operation can be carried out at room temperature, it is preferable to carry out the extraction operation at a temperature of about 60 to 120°C.
以上の如くして得られた抗活性酸素作用物質を含む抽出
液は常法により減圧上濃縮乾固する。The extract containing the anti-active oxygen substance obtained as described above is concentrated to dryness under reduced pressure in a conventional manner.
要すれば凍結乾燥して本発明の抗活性酸素作用組成物が
得られる。なお活性成分はアルカリ側でやや不安定であ
るので、抽出、精製過程は中性乃至酸性側で行なわれる
のが好ましい。If necessary, the anti-reactive oxygen composition of the present invention can be obtained by freeze-drying. Note that since the active ingredient is somewhat unstable on an alkaline side, the extraction and purification steps are preferably carried out on a neutral or acidic side.
以上のようにして得られた本発明の組成物はその精製度
によって種々変化するが、黄乃至茶褐色のあめ状乃至固
型状物であって、アルカリ性側でやや不安定である。そ
して、活性酸素(スーパーオキシド、ハイドロオキシラ
ジカル、過酸化水素等)抑制作用、DPPH(1,1−
ジフェニル−2−ピクリルヒドラチル)法によるラジカ
ルスカベンジャー作用、過酸化脂質生成抑制作用、ラッ
ト心室性不整脈防止作用、抗炎症作用を有する。The composition of the present invention obtained as described above varies depending on its degree of purification, but it is a yellow to brown candy-like or solid substance, and is somewhat unstable on the alkaline side. It also suppresses active oxygen (superoxide, hydroxyl radical, hydrogen peroxide, etc.), DPPH (1,1-
It has a radical scavenging effect using the diphenyl-2-picrylhydratyl method, an inhibitory effect on lipid peroxide production, an antiventricular arrhythmia preventive effect in rats, and an anti-inflammatory effect.
これらの作用は何れも生体内に生成した活性酸素や過酸
化脂質によって引き起される障害を抑制する能力を有す
ることを示すものである。All of these effects indicate that the drug has the ability to suppress damage caused by active oxygen and lipid peroxides generated in vivo.
従って、本発明の組成物は前述の健康上の障害、美容上
の障害の予防、治療に有効な物質である。Therefore, the composition of the present invention is an effective substance for the prevention and treatment of the aforementioned health disorders and cosmetic disorders.
本発明の上記抗活性酸素作用物質を含有する抗活性酸素
作用組成物は経口、非経口の医薬品、医薬部外品、化粧
料等の分野で使用される一般の担体、助剤、添加剤等と
常法に従って製剤化して医薬品、化粧料の他各種の製品
とする。The anti-reactive oxygen composition containing the above-mentioned anti-reactive oxygen agent of the present invention is a general carrier, auxiliary agent, additive, etc. used in the fields of oral and parenteral pharmaceuticals, quasi-drugs, cosmetics, etc. Then, it is formulated into pharmaceuticals, cosmetics, and various other products according to conventional methods.
経口剤としては、錠剤、カプセル剤、顆粒剤、細粒剤、
シロップ剤等、非経口剤としては軟膏剤、クリーム、水
剤等の外用剤、無菌溶液剤、懸濁液剤等の注射剤等であ
る。Oral preparations include tablets, capsules, granules, fine granules,
Parenteral preparations such as syrups include external preparations such as ointments, creams, and solutions, and injections such as sterile solutions and suspensions.
これらの製品を医薬として疾患に投与するときは20m
g〜500mgを1日1乃至数回、即ち20mg〜lo
oomgの全日量で投与し、充分その効果を奏し得るも
のである。20m when administering these products as medicines for diseases.
g~500mg once or several times a day, i.e. 20mg~lo
It can be administered at a total daily dose of oomg to achieve its full effect.
本発明の上記抗活性酸素作用組成物を食品に添加する場
合は、上記製剤の形態でもよいが、あめ、せんべい、ク
ツキーなどの形態でそれぞれの食品原料に所要量を加え
て、一般の製造法により加工製造する。健康食品、機能
性食品としての摂取は、病気予防、健康維持に用いられ
るので、経口摂取として1日数回に分け、全日量として
50mg〜500mgを含む加工品として摂取される。When the anti-active oxygen composition of the present invention is added to food, it may be in the form of the above-mentioned preparation, but it can be added to the respective food raw materials in the form of candy, rice crackers, kutuki, etc. in the required amount, and then added to the food using the general manufacturing method. Processed and manufactured by. Since ingestion as a health food or functional food is used for disease prevention and health maintenance, it is orally ingested several times a day as a processed product containing a total daily dose of 50 mg to 500 mg.
また本発明組成物は、ビタミンC1ビタミンE、補酵素
Qnなど一部抗酸化性を有する化合物と併用することが
出来る。またこれらの物質は、本組成物の安定化剤とし
ての作用も有し、併用することが有用である。これら抗
酸化物質は常用量以下で用いられる。Further, the composition of the present invention can be used in combination with some compounds having antioxidant properties, such as vitamin C, vitamin E, and coenzyme Qn. These substances also act as stabilizers for the present composition, and are useful in combination. These antioxidants are used in less than conventional doses.
本発明の抗活性酸素組成物は医薬品としては生理的に認
められるベヒクル、担体、賦形剤、結合剤、防腐剤、安
定剤、香味剤等と共に要求される単位用量形態に混和さ
れる。一般に抗活性酸素作用組成物を20〜500mg
含有させる。The anti-reactive oxygen compositions of the present invention are incorporated into the required unit dosage form with pharmaceutically acceptable physiologically acceptable vehicles, carriers, excipients, binders, preservatives, stabilizers, flavoring agents, and the like. Generally, 20 to 500 mg of anti-active oxygen composition
Contain.
錠剤、カプセル剤等に混和される佐薬は次のようなもの
である。トラガント、アラビアゴム、コーンスターチ、
ゼラチンのような結合剤、微品性セルロースのような賦
形剤、コーンスターチ、前ゼラチン化澱粉、アルギン酸
のような膨化剤、ステアリン酸マグネシウムのような潤
滑剤、ショ糖、乳糖、サッカリンのような甘味剤、ペパ
ーミント、アカモノ油、チェリーのような香味剤、カプ
セル剤の場合は、上記の材料に更に脂油のような液体担
体を含有することができる。また、他の材料は被覆剤と
して又は製剤の物理的形態を別な方法で変化させるため
に存在させることができる。例えば、錠剤はシェラツク
、砂糖で被覆することができる。シロップ又はエリキシ
ルは本発明の活性組成物に加えて甘味剤としてショ糖、
防腐剤としてメチル又はプロピルパラベン、色素及びチ
ェリー又はオレンジ香味のような香味剤を含有すること
ができる。Adjuvants mixed into tablets, capsules, etc. are as follows. tragacanth, gum arabic, cornstarch,
Binders such as gelatin, excipients such as microcellulose, cornstarch, pre-gelatinized starch, leavening agents such as alginic acid, lubricants such as magnesium stearate, sucrose, lactose, saccharin. Sweetening agents, flavoring agents such as peppermint, red radish oil, and cherry, and in the case of capsules, the above materials can also contain a liquid carrier such as a fatty oil. Other materials can also be present as coatings or to otherwise modify the physical form of the formulation. For example, tablets may be coated with shellac or sugar. A syrup or elixir may contain, in addition to the active composition of the invention, sucrose as a sweetening agent.
Methyl or propyl parabens as preservatives, dyes and flavoring agents such as cherry or orange flavor may be included.
注射剤のための無菌組成物は注射用水のようなベヒクル
中の本発明の活性組成物、ゴマ油、ヤシ油、落花生油、
綿実油等のような天然産出植物油又はエチルオレエート
等のような合成脂肪ベヒクルを溶解又は懸濁させる通常
の方法によって処方することができる。また、緩衝剤、
防腐剤、酸化防止剤等を必要に応じて配合することがで
きる。Sterile compositions for injection include the active composition of the invention in a vehicle such as water for injection, sesame oil, coconut oil, peanut oil,
They can be formulated by conventional methods of dissolving or suspending naturally occurring vegetable oils such as cottonseed oil or the like or synthetic fatty vehicles such as ethyl oleate and the like. In addition, buffering agents,
Preservatives, antioxidants, etc. can be added as necessary.
外用剤としては、基剤としてワセリン、パラフィン、油
脂類、ラノリン、マクロゴール等を用い、通常の方法に
よって軟膏剤、クリーム剤等とする。For external preparations, petrolatum, paraffin, oils and fats, lanolin, macrogol, etc. are used as bases, and ointments, creams, etc. are prepared by conventional methods.
次に本発明の組成物の実施例及び本発明組成物の効果を
示す試験例を挙げる。本実施例は本発明の詳細な説明す
る目的で特に好ましい態様を示したもので、本発明はこ
れに制限されるものではない。Next, Examples of the composition of the present invention and test examples showing the effects of the composition of the present invention will be given. This example shows a particularly preferred embodiment for the purpose of explaining the present invention in detail, and the present invention is not limited thereto.
参考例:本発明の原料物質の製造
大豆、はとむぎ、小麦胚芽、米ぬか、玄米胚芽をそれぞ
れ95〜98℃で約60分焙煎し、各1.0重量部ずつ
混合した後、蒸気で柔らかくなるまで蒸す。これに市販
の麹を適量加え、時々よくかき混ぜて約2,3日間醗酵
させる。これを風乾したのち細粉化する。これに煎り黒
ごまをすっだものを1.5部、抹茶0.5部を加え混合
し、本発明の原料米を得る。Reference example: Manufacture of raw materials of the present invention Soybean, pearl barley, wheat germ, rice bran, and brown rice germ are each roasted at 95 to 98°C for about 60 minutes, mixed with 1.0 part by weight of each, and then softened with steam. Steam until Add an appropriate amount of commercially available koji to this, stir well from time to time, and ferment for about 2 to 3 days. This is air-dried and then ground into a fine powder. To this, 1.5 parts of roasted black sesame seeds and 0.5 parts of matcha are added and mixed to obtain raw rice of the present invention.
実施例1
参考例で得られた原料米20gをn−ヘキサン100−
に懸濁し、常温で1時間撹拌し、静置した後、上澄を可
及的に傾瀉法で除き、更に同様に2回洗浄して固型物を
濾取、風乾し固型分15.5 gを得る。かくして得ら
れた固型分15.5 gをエタノール50ndに懸濁し
、水浴(88〜90℃)中で30分撹拌しながら煮沸す
る。放冷後濾過し、濾取した固体をエタノール約30m
1で洗い、得られた固体を更にエタノール5〇−を加え
、前記と同様に加熱抽出し、放冷後濾過する。エタノー
ル部を合し減圧下に蒸発乾固すると茶褐色半固型状の抗
活性酸素作用組成物1.4gを得る。Example 1 20g of raw rice obtained in the reference example was mixed with n-hexane 100-
After stirring at room temperature for 1 hour and allowing it to stand, the supernatant was removed as much as possible by decantation, and the solids were washed twice in the same manner, filtered, and air-dried to reduce the solid content to 15. Obtain 5 g. 15.5 g of the solid thus obtained is suspended in 50 nd of ethanol and boiled in a water bath (88-90°C) for 30 minutes with stirring. After cooling, filter and add about 30ml of ethanol to the filtered solid.
1, and the obtained solid is further added with 50 ml of ethanol, heated and extracted in the same manner as above, allowed to cool, and then filtered. The ethanol portions were combined and evaporated to dryness under reduced pressure to obtain 1.4 g of a brown semi-solid anti-active oxygen composition.
実施例2
実施例1で得られた抗活性酸素物質1.3gにエタノー
ル15−を加えよく撹拌すると灰褐色固体が析出する、
これを濾別、エタノール溶液に150mgの活性炭を加
えよくふりまぜたのち、活性炭を濾別し、エタノール液
を減圧濃縮すると、黄褐色半固型あめ状の抗活性酸素作
用組成物0.9gを得る。Example 2 When 15-ethanol was added to 1.3 g of the anti-active oxygen substance obtained in Example 1 and stirred thoroughly, a grayish brown solid was precipitated.
After separating this by filtration, adding 150 mg of activated carbon to the ethanol solution and stirring well, the activated carbon was separated by filtration, and the ethanol solution was concentrated under reduced pressure to obtain 0.9 g of a yellow-brown semi-solid candy-like anti-active oxygen composition. obtain.
実施例3
実施例1で得られた抗活性酸素作用組成物5gを水5(
ldに加え乳濁液とし、これをベンゼン8072ずつで
5回洗浄する。後水層を酢酸エチル70威ずつで3回抽
出し、水層を食塩で飽和し、さらに酢酸エチル7o−ず
つで2回抽出する。各酢酸エチル抽出液を合わせ、無水
硫酸ナトリウムで乾燥し、濃縮乾固すると黄褐色粉末の
抗活性酸素作用組成物1.35gを得る。Example 3 5 g of the anti-active oxygen composition obtained in Example 1 was added to 5 g of water (
ld to form an emulsion, which is washed five times with benzene 8072 each. The aqueous layer was extracted three times with 70 parts of ethyl acetate, the aqueous layer was saturated with common salt, and further extracted twice with 7 parts of ethyl acetate. The ethyl acetate extracts are combined, dried over anhydrous sodium sulfate, and concentrated to dryness to obtain 1.35 g of an anti-active oxygen composition as a yellowish brown powder.
実施例4
実施例1の製法において、エタノールに代えて水:アセ
トン(1: 4)の混合液を用い同様に操作すると茶褐
色半固型物の抗活性酸素作用組成物3.1gを得る。Example 4 In the same manner as in Example 1, using a mixture of water and acetone (1:4) instead of ethanol, 3.1 g of an anti-active oxygen composition in the form of a brown semi-solid is obtained.
実施例5
参考例で得られた原料米5gをソックスレー抽出器を用
いてn−ヘキサンで洗浄した固体3.8gに水100威
を加え、100℃、30分加熱抽出する。同じ操作を2
回行い、水溶部を集め減圧濃縮し、更に凍結乾燥し、黄
褐色半固型状の本発明の抗滑性酸素作用組成物0.4g
を得る。Example 5 5 g of raw rice obtained in Reference Example was washed with n-hexane using a Soxhlet extractor, 100 g of water was added to 3.8 g of solid, and the mixture was heated and extracted at 100° C. for 30 minutes. Same operation 2
The aqueous portion was collected and concentrated under reduced pressure, and then freeze-dried to obtain 0.4 g of the anti-slip oxygenated composition of the present invention in the form of a yellowish brown semi-solid.
get.
実施例6
参考例で得られた原料米5gをn−ヘキサン25威に懸
濁し、常温で1時間撹拌し、後静置し、上澄を可及的に
傾瀉法で除き、更に同様に2回洗浄して固型物を濾取し
た。この固型物をベンゼン25−ずつで、上記n−ヘキ
サンで行ったと同様の操作により3回洗浄し、固型物を
濾取し乾燥する。この固型物を酢酸エチルに懸濁し、水
浴中(88〜90℃)で30分撹拌しつつ煮沸し抽出す
る。放冷後濾過し、15dの酢酸エチルで洗う。更に得
られた固体を前記と同様の操作で酢酸エチルで2回熱抽
出を繰り返す。以上の操作で得られた酢酸エチル抽出液
を合わせ、水洗し後無水硫酸ナトリウムで乾燥し、減圧
下で蒸発乾固すると黄褐色粉末状の抗滑性酸素作用組成
物0.13 gを得る。Example 6 5 g of the raw rice obtained in Reference Example was suspended in 25 g of n-hexane, stirred at room temperature for 1 hour, then left to stand, the supernatant was removed as much as possible by decanting, and the suspension was further dissolved in the same manner. It was washed twice and the solid matter was collected by filtration. This solid material is washed three times with 25 parts of benzene and in the same manner as that performed with n-hexane, and the solid material is filtered and dried. This solid substance is suspended in ethyl acetate and extracted by boiling in a water bath (88-90°C) for 30 minutes while stirring. After cooling, it is filtered and washed with 15 d of ethyl acetate. Furthermore, the obtained solid was subjected to thermal extraction twice with ethyl acetate in the same manner as above. The ethyl acetate extracts obtained in the above procedure were combined, washed with water, dried over anhydrous sodium sulfate, and evaporated to dryness under reduced pressure to obtain 0.13 g of an anti-slip composition in the form of a yellowish brown powder.
実施例7
実施例6の製法において、酢酸エチルに代えてメチルイ
ソブチルケトンを用い同様に操作すると黄褐色粉末状の
抗滑性酸素作用組成物0.14■を得る。Example 7 The same procedure as in Example 6 was repeated using methyl isobutyl ketone in place of ethyl acetate to obtain 0.14 mm of an anti-slip oxygen-active composition in the form of a yellowish brown powder.
実施例8 カプセル剤、錠剤
抗滑性酸素作用組成物 15乳
糖 70ステアリン酸マ
グネシウム 15各重量部を均一に混合し
、カプセル剤又は錠剤とする。Example 8 Capsule, tablet anti-slip oxygen composition 15 milk
70 parts by weight of sugar and 15 parts by weight of magnesium stearate are mixed uniformly to form capsules or tablets.
実施例9 散剤、顆粒剤
抗滑性酸素作用組成物 30澱
粉 30乳 糖
40各重量部を均一に混合
し、散剤、顆粒剤とする。Example 9 Powder, granule anti-slip oxygen composition 30 lees
Mix 30 parts by weight of powder and 40 parts by weight of lactose to make a powder or granules.
実施例IO注射剤
抗滑性酸素作用組成物 2界面活性剤
8
生理食塩水 90
各重量部をを加熱混合、滅菌して注射剤とする。Example IO Injectable anti-slip oxygen composition 2 Surfactant 8 Physiological saline 90 Parts by weight are heated and mixed and sterilized to prepare an injection.
実施例11 クツキー
抗活性酸素作用組成物2%重量を含む/JX麦粉に、食
塩、ショ糖、バターなどで味付けしたものを適量の水で
よく撹拌し190〜200℃で30分焼き上げてクツキ
ーとする。Example 11 Containing 2% weight of Kutsky anti-active oxygen composition/JX wheat flour seasoned with salt, sucrose, butter, etc., stirred well with an appropriate amount of water and baked at 190-200°C for 30 minutes to make Kutsky. do.
実施例12 ゼリー
寒天13gを水1℃に加熱溶解し、さらにショ糖500
g、水あめ150g及び塩少々を加え、撹拌しながら加
熱溶解させた後、2%重量の抗滑性酸素組成物、果汁、
着色料、香料などを加えて冷却しゼリーとする。Example 12 13g of jelly agar was heated and dissolved in water at 1°C, and 500g of sucrose was added.
g, 150 g of starch syrup and a little salt were added, heated and dissolved with stirring, and then 2% by weight of anti-slip oxygen composition, fruit juice,
Add colorants, flavors, etc. and cool to make jelly.
実施例13 あ め
ショ糖20重量部、水あめ(75%固型分) 10重量
部に水10重量部を加え混合し150℃に加熱撹拌後、
2%重量の抗滑性酸素作用組成物、及び着色料、香料等
を加え冷却してあめとする。Example 13 Add 10 parts by weight of water to 20 parts by weight of sucrose and 10 parts by weight of starch syrup (75% solids), mix, heat to 150°C and stir,
Add 2% by weight of the anti-slip oxygen composition, coloring agent, flavoring agent, etc., and cool to make a candy.
実施例14 ハンドローション剤
カーボワックス1500 15重量部、アルコール8重
量部及びプロピレングリコール90重量部をよく混合溶
解し、水52.5重量部、抗滑性酸素作用組成物2重量
部及び香料、防腐剤の適量を加えハンドローション剤と
する。Example 14 15 parts by weight of hand lotion Carbowax 1500, 8 parts by weight of alcohol, and 90 parts by weight of propylene glycol were thoroughly mixed and dissolved, and 52.5 parts by weight of water, 2 parts by weight of anti-slip oxygen composition, fragrance, and preservative were added. Add an appropriate amount of the agent to make a hand lotion.
実施例15 外用剤(処方例1)
パラオキシ安息香酸エチル 0.1パラオキ
シ安息香酸ブチル 0,1ラウロマクロゴー
ル 0,5セタノール
I8
白色ワセリン 40
水 36.3抗
活性酸素作用組成物 6各重量部の各成
分を用い抗滑性酸素作用組成物は水に溶解し、常法に従
って軟膏とする。Example 15 External preparation (Formulation example 1) Ethyl paraoxybenzoate 0.1 Butyl paraoxybenzoate 0.1 Lauromacrogol 0.5 Cetanol
I8 White petrolatum 40 Water 36.3 Anti-active oxygen composition 6 The anti-slip oxygen composition is dissolved in water using 6 parts by weight of each component and made into an ointment according to a conventional method.
実施例16 外用剤(処方例2)
ポリエチレングリコール 40ステアレート
3.1グリセリールステアレート
7.7
ベヘエニールアルコール 8.5スクワレ
ン 12.3
グリセリントリオクタノエート 12.3プロピ
ルパラベン 0.1メチルパラベ
ン 0.1シソジユウムEDT
A O,3ジプロピレングリコ
ール 7.7クエン酸 0.2
クエン酸ナトリウム 1.4抗活性
酸素作用組成物 6.0水
40.3各重量部の各成分
を用い抗活性酸素作用組成物は水に溶解し、常法に従っ
て軟膏とする。Example 16 External preparation (Formulation example 2) Polyethylene glycol 40 Stearate 3.1 Glyceryl stearate 7.7 Behenyl alcohol 8.5 Squalene 12.3 Glycerin trioctanoate 12.3 Propyl paraben 0.1 Methyl paraben 0.1 perilla EDT
A O,3 dipropylene glycol 7.7 Citric acid 0.2 Sodium citrate 1.4 Antiactive oxygen composition 6.0 Water
The anti-active oxygen composition is dissolved in water using 40.3 parts by weight of each component and made into an ointment according to a conventional method.
次に本発明の組成物のラジカルスカベンジャー作用の試
験例を示す。Next, a test example of the radical scavenging effect of the composition of the present invention will be shown.
試験例 ラジカルスカベンジャー作用
1) 試験方法
M、S、Blois : Nature 4617,1
+99 (1958)(抗酸化作用)
及び寿野他:武田研究所報44.30 (1985)に
記載の方法に従って行った。Test example Radical scavenger action 1) Test method M, S, Blois: Nature 4617,1
+99 (1958) (antioxidant effect) and Hisano et al.: Takeda Research Institute Bulletin 44.30 (1985).
2) 供試物質
イ) 実施例1で得られた本発明の組成物口) α−ト
コフェルール(対照)
3)結果
以上の結果より明らかな通り、本発明組成物はラジカル
スカベンジャー作用を有し、その活性の強さはα−トコ
フェロールに近い値を示した。2) Test substance a) Composition of the present invention obtained in Example 1) α-tocopherol (control) 3) Results As is clear from the above results, the composition of the present invention has a radical scavenging action. The strength of its activity was close to that of α-tocopherol.
〔発明の効果]
本発明は極めて強い抗活性酸素作用を有する新規組成物
である。そして、この組成物を含有する抗活性酸素剤及
び医薬品は近年、動脈硬化症、脳卒中症、高血圧症、心
筋梗塞症、癌、糖泳病等の成人病を始め、悪性関節リウ
マチ、バーチエツト病、クーロン氏病、潰瘍性大腸炎、
肝炎、腎炎等の難病、化学物質(例えば農薬等)で惹起
される疾患等の健康維持上障害、火傷などの外傷、ニキ
ビ、シラシン、皮膚炎、シミ、ソバカス等の美容上障害
の予防、治療に効果があり、更に本組成物を含有する食
品は上記各種の疾病の予防治療に有効である極めて有用
な発明である。[Effects of the Invention] The present invention is a novel composition that has an extremely strong anti-active oxygen effect. In recent years, anti-active oxygen agents and pharmaceuticals containing this composition have been used to treat adult diseases such as arteriosclerosis, stroke, hypertension, myocardial infarction, cancer, and glycosylosis, as well as malignant rheumatoid arthritis, Bartchet's disease, Coulomb's disease, ulcerative colitis,
Prevention and treatment of intractable diseases such as hepatitis and nephritis, health maintenance disorders such as diseases caused by chemical substances (e.g. pesticides, etc.), injuries such as burns, and cosmetic disorders such as acne, cilantro, dermatitis, age spots, and freckles. Furthermore, the food containing the present composition is an extremely useful invention that is effective in preventing and treating the various diseases mentioned above.
Claims (1)
したものに植物種子を加えて得られる組成物を非極性溶
媒で洗浄し、その後不溶物を極性溶媒で抽出してなるこ
とを特徴とする抗活性酸素作用組成物。 2、請求項1記載の組成物を含有することを特徴とする
抗活性酸素剤。 3、請求項1記載の組成物を含有することを特徴とする
食品。 4、請求項1記載の組成物を含有することを特徴とする
化粧料。 5、請求項1記載の組成物を含有することを特徴とする
医薬品。[Claims] 1. After roasting plant seeds and/or embryos, the plant seeds are added to the enzyme-treated mixture, the resulting composition is washed with a non-polar solvent, and then the insoluble matter is removed with a polar solvent. An anti-reactive oxygen composition characterized in that it is obtained by extraction. 2. An anti-active oxygen agent containing the composition according to claim 1. 3. A food product containing the composition according to claim 1. 4. A cosmetic comprising the composition according to claim 1. 5. A pharmaceutical product comprising the composition according to claim 1.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2257485A JPH07119176B2 (en) | 1990-09-28 | 1990-09-28 | Anti-active oxygen acting composition and anti-active oxygen agent containing the same as an active ingredient, food, cosmetics and pharmaceuticals |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2257485A JPH07119176B2 (en) | 1990-09-28 | 1990-09-28 | Anti-active oxygen acting composition and anti-active oxygen agent containing the same as an active ingredient, food, cosmetics and pharmaceuticals |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH04139132A true JPH04139132A (en) | 1992-05-13 |
JPH07119176B2 JPH07119176B2 (en) | 1995-12-20 |
Family
ID=17306953
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2257485A Expired - Fee Related JPH07119176B2 (en) | 1990-09-28 | 1990-09-28 | Anti-active oxygen acting composition and anti-active oxygen agent containing the same as an active ingredient, food, cosmetics and pharmaceuticals |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH07119176B2 (en) |
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0656669A (en) * | 1992-06-11 | 1994-03-01 | Asahi Breweries Ltd | Pterine derivative preparation having active oxygen-scavenging action |
JPH0799887A (en) * | 1993-09-30 | 1995-04-18 | Hokueiken Corp:Kk | Additive to edible oil |
JPH07188042A (en) * | 1993-12-27 | 1995-07-25 | Soken Kk | Medicine of stupe |
WO1995019716A1 (en) * | 1994-01-19 | 1995-07-27 | Yoshihide Hagiwara | Process for producing embryo extract |
CN1065433C (en) * | 1992-06-22 | 2001-05-09 | 丹羽笑代 | Oily preparation and method of production thereof |
EP1588711A1 (en) * | 2004-04-21 | 2005-10-26 | AOL Corporation | Composition trapping radicals in organism |
US7112344B2 (en) | 2003-08-11 | 2006-09-26 | I-Hung Chu | Vapor fraction from seeds of Glycine max (L.)Merr. and composition thereof |
US7282226B2 (en) | 2003-08-11 | 2007-10-16 | I-Hung Chu | Vapor fraction from seeds of Glycine max (L.) Merr. and composition thereof |
CN102512350A (en) * | 2011-12-16 | 2012-06-27 | 罗芸 | Preparation method for acne-removing cream |
CN102670479A (en) * | 2012-05-21 | 2012-09-19 | 南宁冠华农业科技有限公司 | Traditional Chinese medicine antiphlogistic acne-pullout cosmetic cream and preparation method thereof |
CN110547454A (en) * | 2019-10-14 | 2019-12-10 | 刘发兴 | Formula and preparation method of acne-removing food |
US10543243B2 (en) | 2016-06-06 | 2020-01-28 | Charsire Biotechnology Corp. | Soybeam seed extract, method for producing the same and uses thereof |
US11083766B2 (en) | 2019-05-06 | 2021-08-10 | Charsire Biotechnology Corp. | Uses of soybean seed extract composition for alleviating cancer pain and/or treating cancer skin inflammation |
-
1990
- 1990-09-28 JP JP2257485A patent/JPH07119176B2/en not_active Expired - Fee Related
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0656669A (en) * | 1992-06-11 | 1994-03-01 | Asahi Breweries Ltd | Pterine derivative preparation having active oxygen-scavenging action |
CN1065433C (en) * | 1992-06-22 | 2001-05-09 | 丹羽笑代 | Oily preparation and method of production thereof |
JPH0799887A (en) * | 1993-09-30 | 1995-04-18 | Hokueiken Corp:Kk | Additive to edible oil |
JPH07188042A (en) * | 1993-12-27 | 1995-07-25 | Soken Kk | Medicine of stupe |
WO1995019716A1 (en) * | 1994-01-19 | 1995-07-27 | Yoshihide Hagiwara | Process for producing embryo extract |
US7112344B2 (en) | 2003-08-11 | 2006-09-26 | I-Hung Chu | Vapor fraction from seeds of Glycine max (L.)Merr. and composition thereof |
US7282226B2 (en) | 2003-08-11 | 2007-10-16 | I-Hung Chu | Vapor fraction from seeds of Glycine max (L.) Merr. and composition thereof |
EP1588711A1 (en) * | 2004-04-21 | 2005-10-26 | AOL Corporation | Composition trapping radicals in organism |
CN102512350A (en) * | 2011-12-16 | 2012-06-27 | 罗芸 | Preparation method for acne-removing cream |
CN102670479A (en) * | 2012-05-21 | 2012-09-19 | 南宁冠华农业科技有限公司 | Traditional Chinese medicine antiphlogistic acne-pullout cosmetic cream and preparation method thereof |
US10543243B2 (en) | 2016-06-06 | 2020-01-28 | Charsire Biotechnology Corp. | Soybeam seed extract, method for producing the same and uses thereof |
US11083766B2 (en) | 2019-05-06 | 2021-08-10 | Charsire Biotechnology Corp. | Uses of soybean seed extract composition for alleviating cancer pain and/or treating cancer skin inflammation |
CN110547454A (en) * | 2019-10-14 | 2019-12-10 | 刘发兴 | Formula and preparation method of acne-removing food |
Also Published As
Publication number | Publication date |
---|---|
JPH07119176B2 (en) | 1995-12-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5538611B2 (en) | Maillard reaction inhibitor | |
WO2005072684A1 (en) | Process for producing maca extract | |
JP2514860B2 (en) | Hop extract used for elimination of active oxygen and its utilization | |
JPH04139132A (en) | Anti-active oxygen action composition, anti-active oxygen agent, food, cosmetic and medicine containing the same as active ingredient | |
JPH09208484A (en) | Active oxygen-eliminator and composition containing the same | |
KR101793208B1 (en) | A compostion comprising Cotoneaster horizontalis Decne extract having anti-oxidation or anti-inflammation activity | |
KR20190057225A (en) | A composition having anti-oxidation or anti-inflammation comprising Selaginella tamariscina extracts, fractions thereof or compounds isolated therefrom as an active ingredient | |
KR102052523B1 (en) | A composition having anti-bacterial activity comprising Selaginella tamariscina extracts, fractions thereof or compounds isolated therefrom as an active ingredient | |
JP6902329B2 (en) | Inhibitor of sebaceous gland cell activation | |
KR102613550B1 (en) | A ginsenoside complex comprising insoluble substance curcumin | |
TW200401780A (en) | Novel derivative of flavone C-glycoside and composition containing the same | |
KR102561297B1 (en) | A composition for promoting hair growth containing sprout barley and natural substances as an active ingredient | |
WO2005094858A1 (en) | Antidiabetic composition | |
KR101821925B1 (en) | A composition comprising the complex extract of Poncirus trifoliata and Cinnamommum cassia for treating or preventing allergy desmatitis | |
JPH08337536A (en) | Agent for antiactive oxygen, antiactive oxygen agent, cosmetic, food and medicine containing the same as active ingredient | |
JPH03223217A (en) | Composition having antiactive oxygen effect and antiactive oxygen-agent, food, cosmetics and drug containing the same composition as active component | |
JP2007051103A (en) | Antioxidant composition | |
JP2006057012A (en) | Antioxidative composition | |
JP2021095370A (en) | Panax ginseng seeds treated by method comprising steam heat treatment step and/or skin external or internal formulation containing extract thereof | |
KR20050108746A (en) | Composition comprising an extract of trapa japonica flerov. showing antioxidative effect | |
JP2007099671A (en) | Antioxidant composition | |
JP2019182863A (en) | Skin firmness or moisture improving composition | |
JPWO2005056031A1 (en) | Lipase inhibitor | |
KR20150039342A (en) | A composition comprising the complex extract of Poncirus trifoliata and Cinnamommum cassia for treating or preventing allergy desmatitis | |
KR102461868B1 (en) | Method for improving storage stability of capsosiphon fulvescens extract with hair growth promoting effect |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
LAPS | Cancellation because of no payment of annual fees |